Burn is a common form of trauma, and the treatment of burn wounds remains the focus of clinical research. Dihydromyricetin (DMY) exhibits biological activities including antioxidant, anti-inflammatory, and wound-healing promotion, On the other hand, cerium oxide (CeO₂) demonstrates excellent redox properties. This study developed dihydromyricetin-loaded cerium oxide nanoparticles (CeO₂@DMY) to investigate their impact on deep burn wound healing. Methods: CeO₂@APTES was synthesized by a hydrothermal method, followed by covalent modification to load DMY, forming the CeO₂@DMY complexes. In vitro experiments assessed the antioxidant capacity, antibacterial efficacy, cytotoxicity, and anti-inflammatory activity of CeO₂@DMY. In vivo experiments involved subcutaneous injection of CeO₂@DMY into rat burn wounds to evaluate its effects on wound healing. Results: CeO₂@DMY exhibited potent antioxidant and antibacterial capabilities in vitro. It enhanced fibroblast viability and effectively scavenged reactive oxygen species (ROS). In vivo, CeO₂@DMY accelerated wound closure. Histological analysis revealed reduced inflammatory infiltration, increased connective tissue and neovascularization, elevated collagen deposition, and improved collagen alignment in the CeO₂@DMY group. Immunohistochemistry confirmed significantly upregulated expression of CD31 and α-SMA. Conclusion: CeO₂@DMY integrates antioxidant, antibacterial, and anti-inflammatory functions, enables sustained drug release, and promotes burn wound healing. It presents a promising therapeutic strategy for deep burn injuries. .
Wang et al. (Fri,) studied this question.